Cargando…
The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions
BACKGROUND: The present study aimed at examining the inhibitory effect of two atypical neuroleptics iloperidone and lurasidone on the main human cytochrome P450 (CYP) enzymes in pooled human liver microsomes and cDNA-expressed CYP enzymes (supersomes). METHODS: The activity of these enzymes was dete...
Autores principales: | Danek, Przemysław J., Wójcikowski, Jacek, Daniel, Władysława A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704495/ https://www.ncbi.nlm.nih.gov/pubmed/32279279 http://dx.doi.org/10.1007/s43440-020-00102-5 |
Ejemplares similares
-
In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug–drug interactions
por: Wójcikowski, Jacek, et al.
Publicado: (2020) -
The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia
por: Danek, Przemysław J., et al.
Publicado: (2022) -
The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms
por: Danek, Przemysław J., et al.
Publicado: (2021) -
Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
por: Danek, Przemysław J., et al.
Publicado: (2020) -
Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms
por: Danek, Przemysław J., et al.
Publicado: (2021)